Validación del potencial antioxidante de citrus aurantium en Tabasco, México

Validation of the antioxidant potential of citrus aurantium in Tabasco, Mexico

CLAUDINA VILLARREAL MARIA TERESA CADENAS GONZALEZ Francisca Méndez Morales GLORIA IVETTE BOLIO LÓPEZ Manuel Mateo Hernández Villegas Nidia Elena Rivera DAMIANYS ALMENARES LOPEZ Catalina Rivas Morales (2023, [Artículo])

Citrus aurantium L. (Rutaceae), comúnmente conocida como naranja amarga, posee múltiples potenciales terapéuticos. Se realizó un estudio cualitativo experimental con el objetivo de conocer las características del consumo de C. aurantium (CA) en población tabasqueña. Para validar su uso, se preparó un extracto etanólico (85 %) de las hojas secas de CA y se realizó el tamizaje fitoquímico, con posterior cuantificación del contenido de fenoles y flavonoides totales. Posteriormente se determinó actividad antioxidante por el ensayo DPPH y toxicidad aguda con Artemia Salina. Las partes más empleadas de la planta son las hojas para aliviar dolores musculares, síntomas de resfriados. En el estudio fitoquímico se encontraron que el extracto contiene alcaloides, flavonoides, cumarinas, quinonas y taninos. En la cromatografía de capa fina del extracto hidroalcohólico se demostró la presencia de la naringina. Se obtuvo un contenido de fenoles totales de 69.42 ± 3.47 EAG/g MS y de flavonoides totales de 14.78 ± 0.28 EQ/g MS. Contiene actividad antioxidante de 9240 ± nmol TEAC/gMS y el ensayo de toxicidad aguda demostró una toxicidad moderada. Los resultados evidencian que el extracto etanólico al 85 % contiene compuestos fenólicos y flavonoides, permitiendo sostener las propiedades medicinales y farmacológicas conferidas a la planta en el estado de Tabasco.

Citrus aurantium L. (Rutaceae), commonly known as bitter orange, has multiple therapeutic potentials. An experimental qualitative study was carried out with the objective of knowing the characteristics of the consumption of C. aurantium (CA) in the Tabasco population. To validate its use, an ethanolic extract (85 %) was prepared from the dry CA leaves and phytochemical screening was performed, with subsequent quantification of the content of total phenols and flavonoids. Subsequently, antioxidant activity was determined by the DPPH assay and acute toxicity with Artemia salina. The most used parts of the plant are the leaves to relieve muscle pain, cold symptoms. In the phytochemical study it was found that the extract contains alkaloids, flavonoids, coumarins, quinones and tannins. In the thin layer chromatography of the hydroalcoholic extract, the presence of naringin was demonstrated. A total phenol content of 69.42 ± 3.47 EAG/g DM and total flavonoids of 14.78 ± 0.28 EQ/g DM were obtained. It contains antioxidant activity of 9240 ± nmol TEAC/gMS and the acute toxicity test showed moderate toxicity. The results show that the 85% ethanolic extract contains phenolic compounds and flavonoids, allowing to sustain the medicinal and pharmacological properties conferred to the plant in the state of Tabasco.Conclusions: this study showed the existence of phenols and flavonoids, the antioxidant activity of hydroalcoholic extracts from C. aurantium leaves and their moderate toxicity against Artemia salina.

Conflicto de interés: Los autores declaran que no existe ningún conflicto de intereses.

Contribución por autor: DAL: diseño, escritura y revisión del documento, MTCG, MMHV, GIBL, NERL, FMM, ECVI, CRM: asesoría, escritura y revisión del documento.

Financiación o fondos: El presente estudio no conto con ningún apoyo financiero, todo fue con recurso propio de los investigadores.

Conflicto de interés: Los autores declaran que no existe ningún conflicto de intereses.

Contribución por autor: DAL: diseño, escritura y revisión del documento, MTCG, MMHV, GIBL, NERL, FMM, ECVI, CRM: asesoría, escritura y revisión del documento.

Financiación o fondos: El presente estudio no conto con ningún apoyo financiero, todo fue con recurso propio de los investigadores.

Citrus aurantium Antioxidante Fenoles Flavonoides Toxicidad aguda Citrus aurantium Antioxidant Phenol Flavonoids Acute toxicity INGENIERÍA Y TECNOLOGÍA CIENCIAS TECNOLÓGICAS OTRAS ESPECIALIDADES TECNOLÓGICAS OTRAS OTRAS

Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3

OLIVIA CABANILLAS BERNAL (2019, [Artículo])

The variable domain of New Antigen Receptors (vNAR) from sharks, present special characteristics in comparison to the conventional antibody molecules such as: small size (12–15 kDa), thermal and chemical stability and great tissue penetration, that makes them a good alternative source as therapeutic or diagnostic agents. Therefore, it is essential to improve techniques used for the development and selection of vNAR antibodies that recognize distinct antigens. The development of synthetic antibody libraries offers a fast option for the generation of antibodies with the desired characteristics. In this work three synthetic antibody libraries were constructed; without cysteines (Cys), with one Cys and with two Cys residues within its CDR3, with the objective of determining whether the presence or absence of Cys in the CDR3 favors the isolation of vNAR clones from a synthetic library. The libraries were validated selecting against six mammalian proteins. At least one vNAR was found for each of the antigens, and a clone coming from the library without Cys in the CDR3 was selected with all the antigens. In vitro angiogenesis assay with the isolated anti-VEGF antibodies, suggest that these vNARs are capable of inhibiting in vitro angiogenesis. In silico analysis of anti-VEGF antibodies showed that vNARs from synthetic libraries could rival antibodies with affinity maturation by in silico modeling. © 2019 Cabanillas-Bernal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

aquaporin 1, carcinoembryonic antigen, cysteine, fibroblast growth factor 2, glycophorin A, leukemia inhibitory factor, vasculotropin, vasculotropin antibody, angiogenesis inhibitor, antibody, cysteine, lymphocyte antigen receptor, vasculotropin A, a BIOLOGÍA Y QUÍMICA CIENCIAS DE LA VIDA BIOFÍSICA BIOFÍSICA